(Q52928945)

9 May 2018

title

Enhancement of VP1-specific immune responses and protection against EMCV-K challenge by co-delivery of IL-12 DNA with VP1 DNA vaccine. (English)

1 reference

9 May 2018

author

Sang-Jun Ha

2

1 reference

9 May 2018

author name string

Suh YS

1

1 reference

9 May 2018

Lee CH

3

1 reference

9 May 2018

Sin JI

4

1 reference

9 May 2018

Sung YC

5

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

9 May 2018

published in

Vaccine

1 reference

9 May 2018

volume

19

1 reference

9 May 2018

issue

15-16

1 reference

9 May 2018

page(s)

1891-1898

1 reference

9 May 2018

Regulation of human cytolytic lymphocyte responses by interleukin-12

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Tropism and histopathology of the D, B, K, and MM variants of encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Factors affecting the infection of the D variant of encephalomyocarditis virus in the B cells of C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

The atomic structure of Mengo virus at 3.0 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Structure of the mengo virion V. Distribution of the capsid polypeptides with respect to the surface of the virus particle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

Genetic immunization: a new era in vaccines and immune therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900443-6

7 January 2021

10.1016/S0264-410X(00)00443-6

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018